STONKWHISPER
← Back to Intel
Insider ActivityKYMR

Goodman Noah, Chief Business Officer at Kymera Therapeutics, Inc., sold $222K of KYMR

Updated Jun 13, 2026
Goodman Noah Chief Business Officer
Kymera Therapeutics, Inc. · $KYMR
$222K Total Value
2,500 Shares Traded
$89 Price / Share
53,542 Shares Owned After
2026-04-10 Filing Date

Transaction Details

InsiderGoodman Noah
TitleChief Business Officer
CompanyKymera Therapeutics, Inc.
TickerKYMR
Transaction TypeSale
Transaction Date2026-04-09
Shares Traded2,500
Price Per Share$89
Total Value$222K
Filed Date2026-04-10
Accession Number0001193125-26-151393

Ownership Context

Shares Owned After Transaction53,542
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-151393

Other Insider Trades — KYMR

Other Trades by Goodman Noah

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for KYMR — Kymera Therapeutics, Inc. →

Track KYMR insider activity in real time on The Wire →

Get alerts when Goodman Noah files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 13, 2026 at 07:17 UTC

Want real-time data? Access The Wire for live sentiment tracking.